Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
NEW YORK, Oct. 11, 2023 -- Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced...